Access to Artemisinin-Combination Therapy (ACT) and other Anti-Malarials: National Policy and Markets in Sierra Leone
作者： John H. Amuasi , Graciela Diap , Samuel Blay Nguah , Patrick Karikari , Isaac Boakye
DOI: 10.1371/JOURNAL.PONE.0047733
关键词: Private sector 、 Health policy 、 Public sector 、 Socioeconomics 、 Malaria 、 Rural area 、 Geography 、 Public policy 、 National Policy 、 Sierra leone
摘要: Malaria remains the leading burden of disease in post-conflict Sierra Leone. To overcome challenge anti-malarial drug resistance and improve effective treatment, Leone adopted artemisinin-combination therapy artesunate-amodiaquine (AS+AQ) as first-line treatment for uncomplicated P. falciparum malaria. Other national policy anti-malarials include artemether-lumefantrine (AL) an alternative to AS+AQ, quinine artemether complicated malaria; sulphadoxine-pyrimethamine (SP) intermittent preventive (IPTp). This study was conducted evaluate access recommended anti-malarials. A cross-sectional survey 127 medicine outlets (public, private NGO) urban rural areas. The availability on day survey, median prices, affordability available non-policy were calculated. Anti-malarials stocked 79% all surveyed. AS+AQ widely public outlets; AL only NGO sectors. Quinine nearly two-thirds over one-third outlets. SP Non-policy predominantly sector offered free. Among sold at a cost, same price course (US$1.56), tablets (US$0.63), found both injection had cost US$0.31 US$0.47 sector, while compared US$ 0.63 sector. more affordable than two days’ worth wages
harvard.edu
paperity.org参考文章(11)
Graciela Diap, John Amuasi, Isaac Boakye, Ann-Marie Sevcsik, Bernard Pecoul, Anti-malarial market and policy surveys in sub-Saharan Africa Malaria Journal. ,vol. 9, pp. 1- 11 ,(2010) , 10.1186/1475-2875-9-S1-S1
Timothy O. Abuya, Greg Fegan, Abdinasir A. Amin, Willis S. Akhwale, Abdisalan M. Noor, Robert W. Snow, Vicki Marsh, Evaluating Different Dimensions of Programme Effectiveness for Private Medicine Retailer Malaria Control Interventions in Kenya PLoS ONE. ,vol. 5, pp. e8937- ,(2010) , 10.1371/JOURNAL.PONE.0008937
Paul N Newton, Michael D Green, Dallas C Mildenhall, Aline Plançon, Henry Nettey, Leonard Nyadong, Dana M Hostetler, Isabel Swamidoss, Glenn A Harris, Kristen Powell, Ans E Timmermans, Abdinasir A Amin, Stephen K Opuni, Serge Barbereau, Claude Faurant, Ray CW Soong, Kevin Faure, Jonarthan Thevanayagam, Peter Fernandes, Harparkash Kaur, Brian Angus, Kasia Stepniewska, Philippe J Guerin, Facundo M Fernández, Poor quality vital anti-malarials in Africa - an urgent neglected public health priority. Malaria Journal. ,vol. 10, pp. 352- 352 ,(2011) , 10.1186/1475-2875-10-352
Yvonne Rowa, Timothy O Abuya, Wilfred K Mutemi, Sam Ochola, Sassy Molyneux, Vicki Marsh, Factors influencing implementation of the Ministry of Health-led private medicine retailer programmes on malaria in Kenya BMC Public Health. ,vol. 10, pp. 93- 93 ,(2010) , 10.1186/1471-2458-10-93
Timothy Abuya, Abdinasir Amin, Sassy Molyneux, Willis Akhwale, Vicki Marsh, Lucy Gilson, Importance of strategic management in the implementation of private medicine retailer programmes: case studies from three districts in Kenya. BMC Health Services Research. ,vol. 10, pp. 1- 11 ,(2010) , 10.1186/1472-6963-10-S1-S7
Hellen Gelband, Andreas Seiter, A Global Subsidy for Antimalarial Drugs The American Journal of Tropical Medicine and Hygiene. ,vol. 77, pp. 219- 221 ,(2007) , 10.4269/AJTMH.2007.77.219
John H Amuasi, Graciela Diap, Samuel Blay-Nguah, Isaac Boakye, Patrick E Karikari, Baza Dismas, Jeanne Karenzo, Lievin Nsabiyumva, Karly S Louie, Jean-René Kiechel, Access to artesunate-amodiaquine, quinine and other anti-malarials: policy and markets in Burundi Malaria Journal. ,vol. 10, pp. 34- 34 ,(2011) , 10.1186/1475-2875-10-34
Francesco Checchi, Paul Roddy, Sarian Kamara, Arthur Williams, Guy Morineau, Abdul Rahman Wurie, Bona Hora, Nadine de Lamotte, Tim Baerwaldt, Annette Heinzelmann, Alison Danks, Loretxu Pinoges, Aggrey Oloo, Remy Durand, Lisa Ranford-Cartwright, Martin Smet, , Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine. Tropical Medicine & International Health. ,vol. 10, pp. 146- 153 ,(2005) , 10.1111/J.1365-3156.2004.01367.X
Olusoji Adeyi, Rifat Atun, Universal access to malaria medicines: innovation in financing and delivery The Lancet. ,vol. 376, pp. 1869- 1871 ,(2010) , 10.1016/S0140-6736(10)61189-0
Mike Naylor, Tomas Lievens, Tim Ensor, REVIEW OF FINANCING OF HEALTH IN SIERRA LEONE AND THE DEVELOPMENT OF POLICY OPTIONS ,(2008)